Anticoagulant Blood Factor Deficiencies (Protein C)

  • Duane F. Bruley
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 599)


Anti-coagulant proteins are essential to maintain blood hemostatis for the supply of oxygen and nutrients to tissue cells and for the removal of toxic by-products from metabolism. Hereditary or acquired deficiencies of Protein C, Protein S, or Anti-thrombin III can lead to disease states such as deep vein thrombosis (DVT) with the possibility of producing lung emboli. Phenomena named Factor V Lieden can produce a similar pathologic condition.

Anti-coagulant deficiencies, including Factor V Lieden, are HIDDEN blood conditions that can allow blood clot development, especially with trauma to the tissue and circulatory system. It is proposed that all children between ages twelve to fourteen be checked hereditary deficiencies and Factor V Lieden complications. This would require the development of inexpensive assay equipment12.

The present research focuses on the low cost production of Zymogen Protein C via purification from blood plasma Cohn Fraction IV-1. This process is difficult due to the several Homologous Vitamin K dependent proteins in the blood coagulation cascade. Traditional chromatography (ion exchange) cannot achieve the desired separation. Some more exotic technologies are very expensive so our work proposes to use Immobilized Metal Affinity Chromatography (IMAC). It is hoped to produce a lower cost product that can be used prophylactic ally to treat Protein C deficiencies and possibly other coagulation problems.


Deep Vein Thrombosis Factor Versus Immobilize Metal Affinity Chromatography Blood Factor Hereditary Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bicher, H. I., Blood Cell Aggregation in Thrombotic Processes, A Mongraph in The Bannerstone Division of American Lectures in Hematology, Ed. Walter H. Seegers, 835 (1972).Google Scholar
  2. 2.
    Frojmovic, M., G. Nash, S.L. Diamond, “Cell Aggregation and Cell Adhesion in Flow,” Thromb. Haem. 87: 771 (2002).Google Scholar
  3. 3.
    Diamond, S. L., P. Tandon, D. Schmidtke, I. Laurenzi. "Cellular Aggregation in Blood Flow." Comments Theoretical Biol. 8: 1 ((2000).Google Scholar
  4. 4.
    Bruley, D. F., and W. N. Drohan, “Protein C and Related Anticoagulant,” Advances in Applied Biotechnology Series, 11 (1990).Google Scholar
  5. 5.
    Cheng, T., Liu, D., Griffin, J. H. et. al., “Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective,” Nature Medicine, 9: 338 (2003).PubMedCrossRefGoogle Scholar
  6. 6.
    Mosnier, L. O. and J. H. Griffin, “Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor,” Biochem. J., 373: 65 (2003).PubMedCrossRefGoogle Scholar
  7. 7.
    . Scholar
  8. 8.
    Tang, L., Ren, Y.J., Hong, B. and Kang, K.A., “A Fluorophore-mediated, Fiber-optic, Multi-analyte, Immuno-sensing System for the Rapid Diagnosis and Prognosis of Cardiovascular Diseases. ” Journal of Biomedical Optics, 11 (2), 021011, March/April 2006.CrossRefGoogle Scholar
  9. 9.
    Chen, T. American Red Cross, Jerome Holland Laboratories, Rockville, Maryland, USA.Google Scholar
  10. 10.
    Wu, H., and D. F. Bruley, “Chelator, metal ion and buffer studies for protein C separation,” Comparative Biochemistry and Physiology Part A, 132: 213 (2002).CrossRefGoogle Scholar
  11. 11.
    . Wu, H., and D. F. Bruley, “Process Studies for Protein C Separation,” Oxygen Transport to Tissue XXVI in Advances in Experimental Medicine and Biology, in press.Google Scholar
  12. 12.
    Thiessen, E. E., and D. F. Bruley, “Theoretical Studies of IMAC Interfacial Phenomena for the Production of Protein C,” Oxygen Transport to Tissue XXV in Advances in Experimental Medicine and Biology, 540: 183 (2003).Google Scholar
  13. 13.
    Korah, L.K. and K. A. Kang, “Preliminary Study for the Protein C Purification Using Mini-Antibodies Produced from Recombinant E-coli,” M. S. Thorniley, D. K. Harrison, and P. E. James, Oxygen Transport to Tissue XXV in Advances in Experimental Medicine and Biology, Kluwer Academic/Plenum Publishers, 540: 171 (2003).Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Duane F. Bruley
    • 1
  1. 1.College of EngineeringUniversity of Maryland Baltimore CountyBaltimore

Personalised recommendations